NCT lookup

Inclusion Criteria:

* Age 18 to 65 years inclusive at the time of consent.
* Body mass index between 19.0 and 40.0 kg/m2 inclusive.
* Documented history of chronic AD, for at least 1 year prior to screening Visit 1.
* Meets at minimum 1 of the criteria, as follows:

  * History of inadequate response to topical medications for AD
  * Subject intolerance to treatment with topical medications for AD, or
  * Topical medications are otherwise medically inadvisable
* AD that affects ≥ 10% of the body surface area (BSA).
* An EASI score of ≥ 12 at Visit 1 and ≥ 16 at Visit 3 (Day 1).
* An IGA score of ≥ 3.

Exclusion Criteria:

* Any active medical or psychiatric condition, or other reason, that would interfere with evaluation of the investigational product or interpretation of subject safety or study results.
* Any other clinically relevant abnormal findings from physical examination (including vital signs and electrocardiogram \[ECG\]) or from safety laboratory analysis.
* Active dermatologic conditions that might confound the diagnosis of AD or would interfere with the assessment of the skin.
* Known active allergic or irritant contact dermatitis.

• Birmingham, Alabama, United States
• Santa Monica, California, United States
• Jacksonville, Florida, United States
• Miami, Florida, United States
• Orlando, Florida, United States
• Baton Rouge, Louisiana, United States
• Charlotte, North Carolina, United States
• Tulsa, Oklahoma, United States
• Providence, Rhode Island, United States
• Spartanburg, South Carolina, United States
• Memphis, Tennessee, United States
• San Antonio, Texas, United States
• San Antonio, Texas, United States
• Box Hill, Australia
• Carlton, Australia
• East Melbourne, Australia
• Fremantle, Australia
• Berlin, Germany
• Dresden, Germany
• Hamburg, Germany
• Mahlow, Germany
• Bialystok, Poland
• Kielce, Poland
• Lodz, Poland
• Poznan, Poland
• Skierniewice, Poland
• Wroclaw, Poland
• Alcobendas, Spain
• Leganés, Spain
• Seville, Spain
• + 8 more on CT.gov